Humana (HUM) and Cohere Health Expand Prior Authorization Partnership
Get Alerts HUM Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
Revenue Growth %: +25.2%
Join SI Premium – FREE
Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere's prior authorization platform for diagnostic imaging and sleep services.
"Expanding our partnership with Cohere further supports our commitment to improving prior authorization for our members and providers," said
In
"We're pleased Humana will be utilizing our diagnostic imaging and sleep solutions, further strengthening our strategic and ongoing partnership," said
Cohere's prior authorization platform helps providers and patients get to 'yes' more quickly. Cohere's unique blend of real-time analytics and deep, evidence-based clinical intelligence reduces prior authorization denial rates and leads to faster patient access to care.
Cohere processes 5.5 million prior authorizations annually, positively impacting more than 15 million health plan members and 420,000 healthcare providers nationwide.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) Reiterated at Neutral by Cantor Fitzgerald on $30B RFP Medicaid Award
- Humana to sell minority stake in Gentiva for $900 million
- Humana (HUM) PT Raised to $390 at Mizuho
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share